Other
Ascorbic Acid
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Ascorbic Acid is an early-stage landscape with 0 programs across 1 company. The most active players are McGuff Pharmaceuticals, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
18
clinical trials
Completed14 · 78%
Withdrawn2 · 11%
Unknown status2 · 11%
Clinical Trials
Trial Activity
18 trials
Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid.
Completed·FFundación Canaria Rafael Clavijo para la Investigación Biomédica·Phase 4·NCT02073552·472 enrolled
Lead Detoxifying Effects of Ascorbic Acid Among School Going Adolescents of Karachi- A Cluster Randomized Control Trial
Completed·—·Phase 2/3·NCT02745873·144 enrolled
Oral Sulfate Solution (SUPREP) Versus Polyethylene Glycol (PEG) Plus Ascorbic Acid
Completed·—·Phase 4·NCT02761213·200 enrolled
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
Completed·—·Phase 2·NCT00271635·13 enrolled
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
Withdrawn·—·Phase 2·NCT01125449
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)